Unknown

Dataset Information

0

High O-linked N-acetylglucosamine transferase expression predicts poor survival in patients with early stage lung adenocarcinoma.


ABSTRACT: Tumor cell heterogeneity can make selection of appropriate interventions to lung cancer a challenge. Novel biomarkers predictive of disease risk and treatment response are needed to improve personalized treatment strategies. O-GlcNAcylation, the attachment of ?-N-acetylglucosamine (O-GlcNAc) to serine or threonine residues of intracellular proteins, modulates protein functions and is implicated in cancer pathogenesis. O-GlcNAc-transferase (OGT) and O-GlcNAcase (OGA) catalyze O-GlcNAc addition and removal, respectively. We used immunohistochemistry to explore the utility of OGT, OGA, and O-GlcNAc as potential biomarkers for lung adenocarcinoma. We found that high OGT expression is associated with poor overall survival (OS) in both stage I patients (P=0.032) and those at variable stages of disease (P=0.029), and with poor recurrence-free survival (RFS) in stage I patients (P=0.035). High OGT expression is also associated with poorer OS in patients with EGFR wild-type tumors at variable stages (P=0.038). Multivariate analysis indicated that OGT expression is an independent prognostic factor for RFS (HR 2.946, 95% CI: 1.411-6.150, P=0.004) and OS (HR 2.002, 95% CI: 1.183-3.391, P=0.010) in stage I patients. Our findings indicate OGT is a promising biomarker for further classifying early stage lung adenocarcinomas.

SUBMITTER: Lin YC 

PROVIDER: S-EPMC6089550 | biostudies-literature | 2018 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

High <i>O</i>-linked <i>N</i>-acetylglucosamine transferase expression predicts poor survival in patients with early stage lung adenocarcinoma.

Lin Yi-Cheng YC   Lin Chia-Hung CH   Yeh Yi-Chen YC   Ho Hsiang-Ling HL   Wu Yu-Chung YC   Chen Mei-Yu MY   Chou Teh-Ying TY  

Oncotarget 20180724 57


Tumor cell heterogeneity can make selection of appropriate interventions to lung cancer a challenge. Novel biomarkers predictive of disease risk and treatment response are needed to improve personalized treatment strategies. <i>O</i>-GlcNAcylation, the attachment of <i>β</i>-<i>N</i>-acetylglucosamine (<i>O</i>-GlcNAc) to serine or threonine residues of intracellular proteins, modulates protein functions and is implicated in cancer pathogenesis. <i>O</i>-GlcNAc-transferase (OGT) and <i>O</i>-Glc  ...[more]

Similar Datasets

| S-EPMC7225293 | biostudies-literature
| S-EPMC4161219 | biostudies-literature
| S-EPMC8127640 | biostudies-literature
| S-EPMC5386720 | biostudies-literature
| S-EPMC5362451 | biostudies-literature
| S-EPMC3464805 | biostudies-other
| S-EPMC9496975 | biostudies-literature
| S-EPMC8758312 | biostudies-literature
| S-EPMC5129985 | biostudies-literature
| S-EPMC7066024 | biostudies-literature